Navigation Links
Nanomedical Diagnostics Issued Key Patent for AGILE R100, a Graphene Biosensor for Drug Discovery
Date:5/9/2017

The United States Patent and Trademark Office has issued U.S. Patent No. 9,618,476 to Nanomedical Diagnostics, a biotech company pioneering label-free graphene biosensors for use in drug discovery. The patent covers any holistic graphene biosensor system that detects biomolecular interactions and is a foundational patent behind the company’s AGILE R100 platform.

“This patent showcases our company commitment to bringing cutting-edge nanotechnology to the life science world,” says Nanomedical Diagnostics founder and CTO, Dr. Brett Goldsmith, also the inventor named on the patent. “Graphene biosensors solve many problems encountered with current sensing tools and enable capabilities that aren’t possible with existing techniques. We are committed to developing graphene biosensors into sensitive measurement tools that help biomedical researchers make confident decisions earlier. The issuance of this patent demonstrates that.”

The patent issue highlights the achievement of the Nanomedical Diagnostics technology team in developing a novel approach for label-free detection of biomolecular interactions. The ability to leverage graphene biosensors in a user-friendly, complete system enables sensitivity, small sample sizes, portability, and ease of use that open new applications in the fields of drug discovery, disease diagnostics, health monitoring, and biomanufacturing.

AGILE R100 is available for commercial sale, for research use only.

Read the full story at http://www.prweb.com/releases/Nanomedical_Diagnostics/Patent_issued/prweb14317265.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Nanomedical Diagnostics VP Production to Speak at Materials Research Society Spring Meeting
2. Nanomedical Diagnostics Announces Partnership with Rogue Valley Microdevices, Delivering World’s First Successful High-Volume Manufacturing for Graphene Biosensors
3. Nanomedical Diagnostics to Present Field Effect Biosensing for Fragment-Based Drug Discovery at SLAS 2017
4. Nanomedical Diagnostics CEO and CTO to Introduce Electronic Label-Free Assay Based on Field Effect Biosensing Technology at IDTechEx Show
5. Nanomedical Diagnostics launches a new graphene biosensor with unprecedented functionality for small molecule and protein analysis
6. Nanomedical Diagnostics Announces Scientific Advisory Board of Top Scientists and Medical Researchers
7. ClearLight Diagnostics and Researchers at the Indiana Universitys Melvin and Bren Simon Cancer Center Announce a Collaboration to Profile the Tumor Microenvironment in Patients with Breast Cancer
8. Molecular or Immunoassay? Which Technology Will Win the Race for the Point of Care Diagnostics Market?
9. EU Adopts New Diagnostics and Medical Device Regulations, USDM Life Sciences Helps Organizations Comply
10. Personal Genome Diagnostics Announces AACR Annual Meeting 2017 Presentations and Awards
11. Personal Genome Diagnostics Announces Expanded Cancer Testing Contract with U.S. Department of Veteran Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... line of medical marijuana products targeting the needs of consumers who are incorporating ... Kindred takes place in Phoenix, Arizona. , As operators of two successful Valley ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first ... accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their own ...
(Date:10/6/2017)... (PRWEB) , ... October 06, 2017 , ... ... host a lunch discussion and webinar on INSIGhT, the first-ever adaptive clinical trial ... Investigator, Dana-Farber Cancer Institute. The event is free and open to the public, ...
Breaking Biology Technology:
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
(Date:4/11/2017)... BEACH GARDENS, Fla. , April 11, 2017 ... identity management and secure authentication solutions, today announced ... contract by Intelligence Advanced Research Projects Activity (IARPA) ... for IARPA,s Thor program. "Innovation has ... onset and IARPA,s Thor program will allow us ...
(Date:4/11/2017)... 11, 2017 No two people are ... the New York University Tandon School of Engineering ... found that partial similarities between prints are common ... mobile phones and other electronic devices can be ... vulnerability lies in the fact that fingerprint-based authentication ...
Breaking Biology News(10 mins):